“We have summarized some of our findings regarding the response of various subse...
MIAMI, FLORIDA (Sept. 22, 2023) – Researchers at Sylvester Comprehensive Cancer ...
A collaboration between researchers at the University of Illinois Urbana-Champai...
There is a largely untapped energy source along the world’s coastlines: the diff...
Imagine a secret world inside your belly, filled with countless invisible beings...
In a strategic maneuver aimed at streamlining its product portfolio, pharmaceuti...
One year after allying with the shared objective of enhancing health management ...
Recently, AbbVie disclosed positive outcomes from a second phase 3 trial of Boto...
After months of looking into various other possibilities, Fresh Tracks Therapeut...
In May of this year, the FDA issued a full response letter that delayed the laun...
After an unprecedented live return of mice from the International Space Station ...
AbCellera and Regeneron have extended their current multi-target collaboration t...
The European Commission granted approval for The Menarini Group’s Orserdu to tre...
Benelux offers much potential for companies distributing innovative medicines, b...
Fresh Tracks is planning to seek approval for liquidation and dissolution from s...
The US FDA has accepted Takeda’s NDA resubmission for TAK-721 for the short-term...
